Benitec Biopharma Releases Q3 2022 Financial Results

Go back to Benitec Biopharma Releases Q3 2022 Financial Results
(NASDAQ: BNTC) Delayed: 13.03 +0.15 (1.16%)
Previous Close $12.88    52 Week High $5.64 
Open $13.13    52 Week Low $1.20 
Day High $13.47    P/E N/A 
Day Low $12.78    EPS $0.00 
Volume 38,362